Pathways to Your Career

The Pathways to Your Career Seminar Series brings visiting speakers to campus to discuss their path from chemistry degree to their current position. These sessions also educate students about opportunities outside of academia.

Previous speakers have included representatives from industry, government, academic publishing, and biotechnology startups. The series is managed by Professor Rebekka Klausen. Questions may be directed to klausen@jhu.edu.

Pathways Resources

Upcoming Seminars

Career Pathways Seminar – Dr. Nicole Gaudelli

Remsen Hall 233

The Pathways to Your Career Seminar Series brings visiting speakers to campus to discuss their path from Chemistry degree to their current position, as well as to educate students about […]

Career Pathways Seminar – Dr. Marilia Barros

Remsen Hall 233

The Pathways to Your Career Seminar Series brings visiting speakers to campus to discuss their path from Chemistry degree to their current position, as well as to educate students about […]

Upcoming Speakers

Dr. Marilia Barros, Bristol-Myers Squibb

headshot of dr. barrow laughing

Dr. Barros is a biophysicist with expertise in biomolecular interactions working in drug product development. Currently, she works for Bristol-Myers Squibb as a research investigator. She studies the colloidal stability of biotherapeutics to support drug development and new strategies of drug product formulation.

Dr. Barros received her doctorate in physics from Carnegie Mellon University, where she studied lipid-protein interactions and structure of proteins at lipid membranes. During her graduate studies she became a guest researcher at NIST Center for Neutron Research. There she conducted and helped facility users to perform neutron scattering experiments.

After her PhD, she completed her postdoc at Memorial Sloan Kettering Center. She led and developed biophysics research for studying the mechanisms of action of proteins that have implication in both cancer and Alzheimer’s disease.

Darryl A. Boyd, U.S. Naval Research Lab

Darryl Boyd headshot in orange shirt

Dr. Darryl A. Boyd is a Research Chemist at the U.S. Naval Research Lab in Washington, DC. He has a bachelor’s degree from the University of Michigan, and master and doctorate degrees from Purdue University.  He began working at NRL following his tenure there as a National Research Council postdoc. 

He is the 2020 president of the ACS-affiliated Chemical Society of Washington. Finally, he is the founder of Science Made Simple LLC (and its companion site), a company intended to inspire children to take interest in science.

Although his PhD work was in Inorganic Chemistry, he has spent most of his time at NRL developing novel sulfur-based polymers with unique optical properties. He has co-authored more than 20 papers and has five patent disclosures to his credit. He was named to the 2019 National Academy of Engineering “Frontiers in Engineering Class,” the 2019 SPIE class of “Rising Researchers,’ and the 2018 class of Chemical & Engineering News’s “Talented 12.” 

Dr. Nicole Gaudelli, Beam Therapeutics

Dr. Nicole Gaudelli headshot

Dr. Nicole Gaudelli is a research scientist with formal training in mechanistic enzymology and biosynthesis of natural products. She is currently an Associate Director, Head of Gene Editing Technologies at Beam Therapeutics. 

Dr. Gaudelli received her Ph.D. from right here, Johns Hopkins University, in Dr. Craig A. Townsend’s laboratory group where her projects centered around biochemical, mechanistic and structural studies of the thioesterase domain (TE) in the nocardicin non-ribosomal peptide synthetase (NRPS) and in vitro reconstitution of NRPS enzymes involved in monocyclic β-lactam ring formation. 

After her Ph.D., she completed her postdoc at the Broad Institute of MIT and Harvard University in Dr. David R. Liu’s laboratory where she focused on genome editing, CRISPR/Cas9, base-editing and overall synthetic biology. This is where she developed the first ever “molecular machine capable of catalyzing A:T to G:C transition mutations in human gDNA in a programmable manner without double-strand DNA breaks (“ABE”)”.